Skip to main content
Clinical Trials/CTRI/2023/02/049750
CTRI/2023/02/049750
Not yet recruiting
Phase 2

A Randomised Controlled Trial to assess the Efficacy of Jeevantyadi Ghrita Aschyotana and Jeevantyadi Ghrita oral Intake in the Management of Timira w.s.r to Presbyopia

ational Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: H524- Presbyopia
Sponsor
ational Institute of Ayurveda
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients willing to participate in the trial by taking written informed consent.
  • Patients who are 35 years of age and from either sex.
  • Patients having specific symptoms of prathama and dwitiya patalagata timira.
  • Early to moderate presbyopia determined by screening monocular best\-corrected distant visual acuity (VA)

Exclusion Criteria

  • Patient with any active ocular infection.
  • Patients with preauricular lymphadenopathy.
  • Patients with moderate to severe dry eye .
  • Patients with any abnormal lens findings.
  • Patients having intraocular pressure (IOP) that is less than 5 millimeters of mercury (mmHg) or greater than 22 mmHg in either eye.
  • prior diagnosis of ocular hypertension or glaucoma or currently being treated with any type of topical IOP lowering (glaucoma) medication
  • Patients who have abnormal findings on dilated fundus examination in either eye.
  • Patients having known history of retinal detachment or clinically significant retinal disease in either eye.
  • Patients who have had surgical intervention (ocular or systemic) within 6 months prior to visit.
  • Patients with severe systemic illnesses.

Outcomes

Primary Outcomes

Not specified

Similar Trials